Manufacturing Regulatory Updates In Brief: Gelcaps, Co-Crystals And Biosimilars
Executive Summary
FDA announces reporting change for hard gel capsules and wants to reclassify co-crystals; IPRF releases biosimilars template.
You may also be interested in...
Global Template for Sharing Biosimilar Assessment Data Suggested By Regulators Group
Proposal suggests condensing key data and findings into under 10 pages, published in English.
US Q1 Consumer Health Earnings Preview: Label This One Historic And Challenging But Promising
US OTC drug and supplement firms’ reports of results for the first three months of 2024 began on April 19 with P&G. JP Morgan analysts say while “some retailers in the US in particular” are reducing consumer health inventories, for the overall sector they expect “a healthier balance of positive volume and lower pricing contribution.”
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.